the assumption that addressing the factors common to all rare diseases is more effective than looking at each particular condition separately. In this article we present the HemoRec database, established in Poland in 2006, as an example of a registry of rare bleeding disorders. It was implemented in selected treatment centres in the country and is being developed in order to collect data on inherited bleeding disorders and create the basis for data analysis and exchange between all relevant healthcare providers.
Registries of Inherited Bleeding Disorders
European Principles of Haemophilia Care, formulated in 2008 by a panel of experts, 7 stress the importance of collecting data on haemophilia and related bleeding disorders, and recommends that each country should have a national haemophilia patient registry. Most countries across the world use different kinds of local databases, usually led independently by particular haemophilia treatment centres (HTCs), and a central database, held by the leading HTC of the country.
The history and the current status of the Polish registry of patients with inherited bleeding disorders was described recently. International Health 
Conclusion and Discussion
The need for well-designed, informative databases of rare disorders is clearly defined. Accurate and easily accessible data serve patients, physicians, researchers and pharmaceutical companies. In summary, we want to highlight the importance of regional and international registries, especially in the field of rare diseases.
Launching the HemoRec project in Poland and other countries of the EU could be the first step to creating a modern, European database of inherited bleeding disorders, provided that adequate logistical and financial resources are allocated. n
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